Results 11 to 20 of about 3,178,532 (212)

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation

Lung India, 2016
Context: The combination of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) is widely used in the treatment of moderate-to-severe asthma uncontrolled by ICS alone. Aims: To evaluate the efficacy and safety of a new ICS-LABA combination
Sundeep S Salvi, Abhijit J Vaidya, Rahul R Kodgule, Jaideep A Gogtay   +3 more
doaj   +1 more source

Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety

Therapeutic Advances in Respiratory Disease, 2015
The international guidelines on chronic obstructive pulmonary disease (COPD) recommend inhaled bronchodilators for maintenance treatment of the disease. These drugs include β2-agonists and muscarinic antagonists, which are both available as short-acting ...
Erminia Ridolo, Marcello Montagni, Gian Galeazzo Riario-Sforza, Marco Baroni, Cristoforo Incorvaia   +4 more
doaj   +1 more source

Spirometric Indices after Bronchodilator Test in Obstructive Lung Disease [PDF]

Acta Medica Iranica, 2010
"nBronchial responsiveness to bronchodilator medications is usually tested to establish reversibility of airflow obstruction. Among the various tests to establish bronchodilator response, FEV1, FEF25-75% or FEF50%, and FVC are the most widely used ...
Amir Houshang Mehrparvar, Seyed Jalil Mirmohammadi, Mohammad Mehdi Sohrabi   +2 more
doaj   +2 more sources

Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial

BMC Pulmonary Medicine, 2018
Background In exacerbations of chronic obstructive pulmonary disease, administration of high concentrations of oxygen may cause hypercapnia and increase mortality compared with oxygen titrated, if required, to achieve an oxygen saturation of 88–92 ...
George Bardsley, Janine Pilcher, Steven McKinstry, Philippa Shirtcliffe, James Berry, James Fingleton, Mark Weatherall, Richard Beasley   +7 more
doaj   +1 more source

BRONCHIAL RESPONSE TIME TO A BRONCHODILATING AGENT-ORCIPRENALINE

The Keio Journal of Medicine, 1973
The specific airway conductance (Gaw/Vtg) of 4 normal subjects and 5 subjects with respiratory diseases was measured before and after inhalation of orciprenaline. There was an almost maximum increase in Gaw/Vtg within 3 to 4 minutes in both groups of subjects after inhalation of orciprenaline.
Jun Kagawa, Masamichi Tajika, Shizuo Katagiri   +2 more
openaire   +4 more sources

Long-acting β2-adrenergic receptor agonist in pediatric asthma

Allergology International, 2004
Long-acting β2-adrenergic receptor agonists (LABA), a class of agents for the long-term management of childhood bronchial asthma, are recommended for use in combination with steroid inhalation for the treatment of the morning dip in severe childhood ...
Shigemi Yoshihara, Yumi Yamada, Toshio Abe, Osamu Arisaka   +3 more
doaj   +1 more source

Bronchodilator Response in Patients with Persistent Allergic Asthma Could Not Predict Airway Hyperresponsiveness

Allergy, Asthma & Clinical Immunology, 2007
Anticholinergics, or specific antimuscarinic agents, by inhibition of muscarinic receptors cause bronchodilatation, which might correlate with activation of these receptors by the muscarinic agonist methacholine.
Petanjek Bojana B, Grle Sanja P, Pelicarić Dubravka, Vranković Dubravka   +3 more
doaj   +1 more source

Adherence to Inhalation Devices in Patients with Chronic Obstructive Pulmonary Disease

Patient Preference and Adherence, 2023
Luis Fernando Valladales-Restrepo,1– 3 María Camila Oyuela-Gutiérrez,3 Ana Camila Delgado-Araujo,1 Juliana Calvo-Salazar,1 Daniel Osorio-Bustamante,3 Cesar Eduardo Lerma-Barco,3 Jorge Enrique Machado-Alba1 1Grupo de Investigación en Farmacoepidemiología ...
Valladales-Restrepo LF, Oyuela-Gutiérrez MC, Delgado-Araujo AC, Calvo-Salazar J, Osorio-Bustamante D, Lerma-Barco CE, Machado-Alba JE   +6 more
doaj  

COPD and glycopyrronium responsiveness assessment: An appraisal

Lung India, 2023
Clinical Trial Registration: ECR/159/Inst/WB/2013/RR-20 Background: Glycopyrronium bromide (a long-acting antimuscarinic agent: LAMA) appears pharmacokinetically suitable for testing bronchodilator responsiveness as salbutamol (short-acting β2-agonist ...
Parthasarathi Bhattacharyya, Dipanjan Saha, Moumita Chatterjee, Sayoni Sengupta, Debkanya Dey, Rajat Banerjee   +5 more
doaj   +1 more source

Association between body composition, sarcopenia and pulmonary function in chronic obstructive pulmonary disease

BMC Pulmonary Medicine, 2022
Background Chronic Obstructive Pulmonary Disease (COPD) is characterized by progressive and irreversible airflow limitation. Different factors that modify pulmonary function include age, sex, muscular strength, and a history of exposure to toxic agents ...
Nathalie Martínez-Luna, A. Orea-Tejeda, D. González-Islas, L. Flores-Cisneros, C. Keirns-Davis, R. Sánchez-Santillán, Ilse Pérez-García, Y. Gastelum-Ayala, Valeria Martínez-Vázquez, Ó. Martínez-Reyna   +9 more
semanticscholar   +1 more source